These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26499178)

  • 1. Prevalence, Treatment, and Control of Hypercholesterolemia in High Cardiovascular Risk Patients: Evidences from a Systematic Literature Review in Spain.
    de la Sierra A; Pintó X; Guijarro C; Miranda JL; Callejo D; Cuervo J; Subirà R; Rubio M
    Adv Ther; 2015 Oct; 32(10):944-61. PubMed ID: 26499178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnitude and management of hypercholesterolemia in the adult population of Spain, 2008-2010: The ENRICA Study.
    Guallar-Castillón P; Gil-Montero M; León-Muñoz LM; Graciani A; Bayán-Bravo A; Taboada JM; Banegas JR; Rodríguez-Artalejo F
    Rev Esp Cardiol (Engl Ed); 2012 Jun; 65(6):551-8. PubMed ID: 22483404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipid control in diabetic patients in Extremadura (Spain)].
    Roberto Robles N; Barroso S; Marcos G; Sánchez Muñoz-Torrero JF;
    Endocrinol Nutr; 2009 Mar; 56(3):112-7. PubMed ID: 19627723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship.
    Sánchez-Hernández RM; Civeira F; Stef M; Perez-Calahorra S; Almagro F; Plana N; Novoa FJ; Sáenz-Aranzubía P; Mosquera D; Soler C; Fuentes FJ; Brito-Casillas Y; Real JT; Blanco-Vaca F; Ascaso JF; Pocovi M
    Circ Cardiovasc Genet; 2016 Dec; 9(6):504-510. PubMed ID: 27784735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Hypercholesterolemia, Appropriateness of Therapeutic Approaches and New Drugs in Patients with High Cardiovascular Risk.
    Agabiti Rosei E; Salvetti M
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):217-30. PubMed ID: 27567901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia.
    Skoumas I; Masoura C; Pitsavos C; Tousoulis D; Papadimitriou L; Aznaouridis K; Chrysohoou C; Giotsas N; Toutouza M; Tentolouris C; Antoniades C; Stefanadis C
    Int J Cardiol; 2007 Oct; 121(2):178-83. PubMed ID: 17188767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk factor treatment and control in relation to coronary disease risk in the Spanish population of the DARIOS Study].
    Baena-Díez JM; Félix FJ; Grau M; Cabrera de León A; Sanz H; Leal M; Elosua R; Rodríguez-Pérez Mdel C; Guembe MJ; Torán P; Vega-Alonso T; Ortiz H; Pérez-Castán JF; Frontera-Juan G; Lapetra J; Tormo MJ; Segura A; Fernández-Bergés D; Marrugat J
    Rev Esp Cardiol; 2011 Sep; 64(9):766-73. PubMed ID: 21764497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Control of cholesterolemia in Spain, 2000. A tool for cardiovascular prevention].
    Plaza Pérez I; Villar Alvarez F; Mata López P; Pérez Jiménez F; Maiquez Galán A; Casasnovas Lenguas JA; Banegas Banegas JR; Tomás Abadal L; Rodríguez Artalejo F; Gil López E
    Rev Esp Cardiol; 2000 Jun; 53(6):815-37. PubMed ID: 10944975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular risk factors and cardiovascular diseases in patients with moderate to severe psoriasis under systemic treatment. PSO-RISK, descriptive study.
    Vanaclocha F; Belinchón I; Sánchez-Carazo JL; Rivera R; Carrascosa JM; Cea-Calvo L; Juliá B; Puig L
    Eur J Dermatol; 2014; 24(6):662-9. PubMed ID: 25333326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary heart disease and cardiovascular risk factors among people aged 25-65 years, as seen in Romanian primary healthcare.
    Bunescu DM; Stoffers HE; van den Akker M; Jan Dinant G
    Eur J Gen Pract; 2008; 14(2):56-64. PubMed ID: 18720274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiovascular risk profile in 40-year old men and 50-year old women in the Czech Republic: results of a cross-sectional survey].
    Vrablík M; Chmelík Z; Lánská V
    Vnitr Lek; 2014 Nov; 60(11):991-7. PubMed ID: 25600047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Active interventions in hypercholesteroloemia patients with high cardivascular risk in primary care].
    Tárraga López PJ; Garcia-Norro Herreros FJ; Tárraga Marcos L; Solera Albero J; González López E; Ruiz García A; Pallarés Carratalá V; Castro Navarro JL; Alins Presas J; Panisello Royo JM
    Nutr Hosp; 2015 May; 31(5):2261-8. PubMed ID: 25929402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.
    Thomas GS; Cromwell WC; Ali S; Chin W; Flaim JD; Davidson M
    J Am Coll Cardiol; 2013 Dec; 62(23):2178-84. PubMed ID: 24013058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Different approach in high-cardiovascular-risk women, compared to men: a multidisciplinary study-Spain].
    Conthe Gutiérrez P; Lobos Bejarano JM; González Juanatey JR; Gil Núñez A; Pajuelo Fernández FJ; Novials Sardá A;
    Med Clin (Barc); 2003 Apr; 120(12):451-5. PubMed ID: 12689551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project.
    Castañeda S; Martín-Martínez MA; González-Juanatey C; Llorca J; García-Yébenes MJ; Pérez-Vicente S; Sánchez-Costa JT; Díaz-Gonzalez F; González-Gay MA;
    Semin Arthritis Rheum; 2015 Jun; 44(6):618-26. PubMed ID: 26058345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
    Portolés J; López-Gómez JM; Aljama P
    Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
    Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comorbidity and cardiovascular risk in subjects with initial diagnosis of hypercholesterolemia].
    Párraga Martínez I; Campo Del Campo JM; Muñoz Sánchez-Villacañas R; Villena Ferrer A; Morena Rayo S; González Felipe N; López-Torres Hidalgo J
    Rev Esp Salud Publica; 2011 Jun; 85(3):305-13. PubMed ID: 21892555
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.